| |
|
|
 |
|
print
|
|
 |
A Rapid, Fixed-Price Manufacturing Service
In response to growing customer demand, Lonza introduced XSpedite Microbial Services™, an unprecedented fixed-price manufacturing service for rapidly delivering quantities of microbially derived biopharmaceuticals (up to 1g).
Guaranteed Minimum Quantities
Lonza guarantees a minimum quantity will be delivered after an initial lab evaluation. The offering integrates Lonza’s existing and innovative platform technologies and systems to quickly provide non-GMP proteins and plasmid DNA for critical pre-clinical requirements in 10 to 15 weeks (from strain to purified product).
The Right Quality for Proof-of-Concept Studies
The success of a drug development program can be severely and negatively impacted by limited amounts of low-grade material for in vitro or in vivo studies. Much early-stage biotechnology research requires certain quantities of purified material for proof-of-concept studies as a key milestone in the evolution of pre-clinical programs.
Accelerate Early Stage Programs
By facilitating the efficient and rapid development of fermentation expression and purification processes, Lonza’s XSpedite Microbial Services™ enable a customer to cost-effectively accelerate early stage microbial biopharmaceutical programs without having to invest in a full GMP process development program. This service package provides a firm foundation for establishing robust cGMP manufacturing processes necessary for subsequent supplies of toxicology and clinical trial material.
Leverage Lonza's Platform Technologies
The new XSpedite Microbial Services™ are fully aligned and complementary to Lonza’s proprietary platforms for protein molecular modeling (AggreSolve™ Protein Aggregation Predictor) and Lonza’s high-titer XS Microbial Expression Technologies™. The combined services now enable molecular design through rapid strain and process development.
For more information, please contact one of our experts, or email us at microbialbiopharma@lonza.com
|
|
|
|
|
|
|
|
|
|
|
|
 |
